MEDICAL MARIJUANA, INC.’S HEMPMEDS® MEXICO TO HOLD FIRST-EVER NATIONAL SYMPOSIUM ON MEDICAL CANNABIS FOR HEALTH PROFESSIONALS
Company Strengthens Industry Leadership Through Educating Medical Community on Therapeutic Uses of Cannabis for Treating Neurodegenerative DiseasesMedical Marijuana, Inc. (OTC: MJNA) today announced that its subsidiary HempMeds® Mexico will hold the first-ever symposium dedicated to providing the medical community with information about the medical value of cannabidiol (CBD) derivatives in the treatment of neurodegenerative diseases. The First National Symposium on Medical Cannabis, which will take place on Oct. 8 in Mexico City, is